A Phase IIa Trial of TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO): A Double-masked, Randomized Trial to Evaluate Efficacy and Tolerability
Phase of Trial: Phase II
Latest Information Update: 26 Jul 2017
At a glance
- Drugs Dexamethasone (Primary)
- Indications Retinal oedema
- Focus Therapeutic Use
- Sponsors Taiwan Liposome Company
- 19 Apr 2017 Status changed from not yet recruiting to recruiting.
- 06 Apr 2017 Planned initiation date changed from 1 Mar 2017 to 1 Apr 2017.
- 31 Mar 2017 New trial record